article thumbnail

Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype

Bill of Health

Previously, its authors had contributed to a related piece in this Bill of Health blog, which argued for a precautionary approach to touch in psychedelic-assisted therapy.) As each contribution emphasizes, these oversights have ethical implications for research design, informed consent processes, and public communication.

article thumbnail

Intersectionality, Indigeneity, and Disability Climate Justice in Nepal

Bill of Health

Around 65% of ancestral land was located within Nepal’s national parks and reserves by 2015, and many evicted Indigenous Peoples remain landless. NIDWAN disseminated an advocacy statement for disability-inclusive climate action from Indigenous women and girls with disabilities at COP27 and COP 28.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

It includes aspects such as home health visits, remote monitoring and diagnostics, direct-to-patient shipment of study drugs, and electronic informed consent. Decentralization is enabled by the advancement of digital tools, telemedicine, and more mobile and local healthcare.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

This year’s Drug & Device Law Blog top ten decisions of the year reinforced preemption – the most powerful defense we can assert. Plaintiff knew about it, too, since he signed an informed consent document mentioning it. If any of these are your cases, the Blog congratulates you. And lost again on appeal in Cates.

FDA 105